Nrf2 is the master transcriptional regulator of the anti-oxidant response and is known to be important in lung disease, as mice deficient in Nrf2 experience higher mortality, have increased pulmonary edema and inflammation [20,21], and develop pathologic changes similar to those found in BPD [8,22–29]. The gene discussed is NFE2L2; the disease is lung disorder.